Concepedia

Karin Levie

KL

6

Publications

322

Citations

6

H-Index

2002

Active since

Affiliations

UCLouvain(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (Belgium)

University of Antwerp

Karin Levie is an author at UCLouvain specializing in viral hepatitis, pediatrics, and vaccination.

Top concepts

Publications per year

2002–2008

6

Publications

6

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers et al. · The Journal of Infectious Diseases · 2008 · 117 citations · Full text

Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents

Dominique Boutriau, Jan Poolman, Ray Borrow et al. · Clinical and Vaccine Immunology · 2007 · 57 citations · Full text

A 2-Dose Regimen of a Recombinant Hepatitis B Vaccine with the Immune Stimulant AS04 Compared with the Standard 3-Dose Regimen of Engerix-B in Healthy Young Adults

Karin Levie, Peter Skinhøj, M. Stoffel · Scandinavian Journal of Infectious Diseases · 2002 · 51 citations

A Single Dose, Combined Vaccine against Typhoid Fever and Hepatitis A: Consistency, Immunogenicity and Reactogenicity

Jiřı́ Beran, M. Beutels, Karin Levie et al. · Journal of Travel Medicine · 2006 · 43 citations · Full text

Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12–15 years

Karin Levie, Jiřı́ Beran, François Collard et al. · Vaccine · 2002 · 34 citations

, , +8

Rows per page

1–5 of 6